Cochlear Limited (COH.AX)

272.29 -0.75 (-0.27%) At close: 04:10PM AEDT

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
61 2 9428 6555
https://www.cochlear.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 4,800

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Diggory William Howitt BE (Hons), MBA	CEO, MD, President & Executive Director	4.78M	N/A	1967
Mr. Stuart Sayers	Chief Financial Officer	1.87M	N/A	N/A
Mr. Jan Janssen MSc Elec Eng	Chief Technology Officer	2.04M	N/A	1965
Ms. Karen O'Driscoll	Chief Information Officer	N/A	N/A	N/A
Ms. Kristina Devon	Vice President of Investor Relations	N/A	N/A	N/A
Rob McGrory	Group General Counsel	N/A	N/A	N/A
Ms. Jennifer Stevenson	VP of Corporate Communications & Brand	N/A	N/A	N/A
Mr. Dean Phizacklea	Senior Vice President of Global Strategic Marketing	N/A	N/A	N/A
Ms. Jennifer Hornery	Senior Vice President of Global People & Culture	N/A	N/A	N/A
Mr. Greg Bodkin BE (Hons), MComm (UNSW)	Senior Vice President of Global Supply Chain	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 1 December 2023 is 1. The pillar scores are Audit: 1; Board: 3; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.